Cargando…
Of Cross-immunity, Herd Immunity and Country-specific Plans: Experiences from COVID-19 in India
India has witnessed a high number of COVID-19 cases, but mortality has been quite low, and most cases have been asymptomatic or mild. In early April, we had hypothesized a low COVID-19 mortality in India, based on the concept of cross-immunity. The presence of cross-immunity is presumed to lead to a...
Autores principales: | Chakrabarti, Sankha Shubhra, Kaur, Upinder, Singh, Anup, Chakrabarti, Suddhachitta, Krishnatreya, Manigreeva, Agrawal, Bimal Kumar, Mittal, Amit, Singh, Amit, Khanna, Rahul, Gambhir, Indrajeet Singh, Jin, Kunlin, Chakrabarti, Sasanka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673860/ https://www.ncbi.nlm.nih.gov/pubmed/33269091 http://dx.doi.org/10.14336/AD.2020.1104 |
Ejemplares similares
-
COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?
por: Chakrabarti, Sankha Shubhra, et al.
Publicado: (2020) -
Rapidly Progressive Dementia with Asymmetric Rigidity Following ChAdOx1 nCoV-19 Vaccination
por: Chakrabarti, Sankha Shubhra, et al.
Publicado: (2022) -
Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India
por: Chakrabarti, Sasanka, et al.
Publicado: (2022) -
APOE4 allele in north Indian elderly patients with dementia or late onset depression-a multiple-disease case control study
por: Misra, Anamika, et al.
Publicado: (2019) -
Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2
por: Kaur, Upinder, et al.
Publicado: (2020)